Showing results (341-350 of 357) with videos related to

Sort By:
Pageof 36
The Journal of Clinical Investigation|July 20, 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollersRadwa Sharaf, Guinevere Q Lee, Xiaoming Sun, et al.
The Journal of Infectious Diseases|September 25, 2021
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.
Science (New York, N.Y.)|November 13, 2020
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivoYixuan J Hou, Shiho Chiba, Peter Halfmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
HIV post-treatment controllers have distinct immunological and virological featuresBehzad Etemad, Xiaoming Sun, Yijia Li, et al.
Nature Medicine|October 2, 2023
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaquesAmir Dashti, Sophia Sukkestad, Anna M Horner, et al.
The Journal of Clinical Investigation|June 15, 2023
Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapyYuyang Tang, Antoine Chaillon, Sara Gianella, et al.
The Journal of Clinical Investigation|September 29, 2015
Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cellsJulia A M Sung, Joy Pickeral, Liqin Liu, et al.
Nature|January 24, 2020
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cellsJulia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, et al.
Pageof 36